| Leroy Ralph Sharer, MD | |
|
150 Bergen St, Newark, NJ 07103-2496 | |
| (973) 972-4770 | |
| (973) 972-5933 |
| Full Name | Leroy Ralph Sharer |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245265081 | NPI | - | NPPES |
| 2234408 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 25MA03858700 (New Jersey) | Primary |
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871503474 PECOS PAC ID: 9830003417 Enrollment ID: O20040427001102 |
News Archive
A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Human sperm may hold the potential to serve as biomarkers of the future health of newborn infants, according to a new study by a Wayne State University School of Medicine research team.
In the spirit of WHO, which regards this problem as one of the ten major healthcare problems in the world - the aim of all participants is to engage with parents, political decision-makers, the media and healthcare professionals, in particular, to raise awareness and hence achieve greater vaccination coverage in general.
Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leroy Ralph Sharer, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: () - | Leroy Ralph Sharer, MD 150 Bergen St, Newark, NJ 07103-2496 Ph: (973) 972-4770 |
News Archive
A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Human sperm may hold the potential to serve as biomarkers of the future health of newborn infants, according to a new study by a Wayne State University School of Medicine research team.
In the spirit of WHO, which regards this problem as one of the ten major healthcare problems in the world - the aim of all participants is to engage with parents, political decision-makers, the media and healthcare professionals, in particular, to raise awareness and hence achieve greater vaccination coverage in general.
Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.
› Verified 1 days ago
Dr. Jie-gen Jiang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen Street, Newark, NJ 07103 Phone: 973-972-4083 Fax: 973-972-5909 | |
Xinlai Sun, MD Pathology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave # L-4, Newark, NJ 07112 Phone: 973-926-7580 Fax: 973-705-8301 | |
Stanley Cohen, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-4145 Fax: 973-972-5909 | |
George P. Studzinski, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-5869 Fax: 973-972-5909 | |
Seena Carol Aisner, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Bergen St, Admc 12 1205, Newark, NJ 07107 Phone: 973-972-0037 | |
Fermina M Mazzella, MD Pathology Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Room C-102, Newark, NJ 07103 Phone: 973-972-4619 Fax: 973-972-3199 |